Earnings

Found 85,389 articles

• Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance

  5/8/2023

  Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the first quarter ending March 31, 2023.

• Arcellx Provides First Quarter 2023 Financial Results

  5/8/2023

  Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported financial results for the first quarter ended March 31, 2023.

• Y-mAbs Reports First Quarter 2023 Financial Results and Recent Corporate Developments and Updates 2023 Financial Guidance

  5/8/2023

  Y-mAbs Therapeutics, Inc. a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, reported financial results for the first quarter of 2023.

• Atrion Reports First Quarter 2023 Results

  5/8/2023

  Atrion Corporation announced its results for the first quarter ended March 31, 2023.

• BioNTech Announces First Quarter 2023 Financial Results and Corporate Update

  5/8/2023

  BioNTech SE reported financial results for the three months ended March 31, 2023, and provided an update on its corporate progress.

• BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023

  5/8/2023

  BiomX Inc. announced that the Company will host a conference call and a live audio webcast on Monday, May 15th, 2023, at 8:00 a.m. ET, to report first quarter 2023 financial results and provide business updates.

• Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023

  5/8/2023

  Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that the Company will release its first quarter 2023 financial results before the opening of the U.S. financial markets on Thursday, May 11, 2023.

• ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

  5/8/2023

  ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended March 31, 2023.

• Certara Reports First Quarter 2023 Financial Results

  5/8/2023

  Certara, Inc., a global leader in biosimulation, reported its financial results for the first quarter of fiscal year 2023.

• McKesson Corporation Reports Fiscal 2023 Fourth-Quarter and Full-Year Results and Raises Long-Term Segment Growth Targets

  5/8/2023

  McKesson Corporation has released its fiscal 2023 fourth-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.

• Almirall’s First Quarter 2023 Results

  5/8/2023

  Almirall, S.A., the global biopharmaceutical company based in Barcelona, has announced its Q1 2023 financial results.

• Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update

  5/8/2023

  Pharvaris reported financial results for the first quarter ended March 31, 2023 and provided a business update.

• CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023

  5/8/2023

  CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023, and will host a corporate update conference call at 4:30pm Eastern Time.

• Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates

  5/8/2023

  Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, May 15, 2023 at 8:30 a.m. Eastern Daylight Time to review first-quarter 2023 financials and provide corporate updates.

• Inhibikase Therapeutics to Report First Quarter Financial Results on May 15, 2023

  5/8/2023

  Inhibikase Therapeutics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023, after the close of U.S. markets.

• DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

  5/8/2023

  DiaMedica Therapeutics Inc. announced today that its first quarter 2023 financial results will be released after the markets close on Monday, May 15th.

• Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023Management to Host Conference Call

  5/8/2023

  Minerva Neurosciences, Inc. today announced that it will release first quarter 2023 financial results and business updates on Monday, May 15, 2023.

• Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023Live conference call on Friday, May 12 at 8:30 a.m. ET

  5/8/2023

  Longeveron Inc. today announced that the Company will release its first quarter 2023 financial results on Friday, May 12, 2023 before the open of the U.S. financial markets.

• OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time

  5/8/2023

  OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first quarter 2023 financial results after the close of the U.S. financial markets on Monday, May, 15th , 2023.

• Quipt Home Medical Announces Date and Time for Fiscal Q2 2023 Conference Call and Audio Webcast

  5/8/2023

  Quipt Home Medical Corp. today announced that it will host its Fiscal Q2 2023 earnings conference call and audio webcast on Tuesday, May 16, 2023 at 10:00 a.m. (ET).